These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25808185)

  • 1. Development and characterization of spray dried microparticles for pulmonary delivery of antifungal drug.
    Mathpal D; Garg T; Rath G; Goyal AK
    Curr Drug Deliv; 2015; 12(4):464-71. PubMed ID: 25808185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
    Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
    Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
    Jung SH; Lim DH; Jung SH; Lee JE; Jeong KS; Seong H; Shin BC
    Eur J Pharm Sci; 2009 Jun; 37(3-4):313-20. PubMed ID: 19491021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.
    Wasan EK; Bartlett K; Gershkovich P; Sivak O; Banno B; Wong Z; Gagnon J; Gates B; Leon CG; Wasan KM
    Int J Pharm; 2009 May; 372(1-2):76-84. PubMed ID: 19236839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations.
    Jansook P; Pichayakorn W; Ritthidej GC
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1693-1700. PubMed ID: 29936874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B Loaded Nanostructured Lipid Carriers for Parenteral Delivery: Characterization, Antifungal and In vitro Toxicity Assessment.
    Nimtrakul P; Tiyaboonchai W; Lamlertthon S
    Curr Drug Deliv; 2019; 16(7):645-653. PubMed ID: 31362675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Sustained Release Oseltamivir Phosphate Dry Powder Inhaler:
    Sahastrabudhe H; Kenjale P; Pokharkar V
    Curr Drug Deliv; 2020; 17(8):703-710. PubMed ID: 32472998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular amphotericin B delivery by chitosan-modified nanostructured lipid carriers for fungal keratitis-targeted therapy.
    Fu T; Yi J; Lv S; Zhang B
    J Liposome Res; 2017 Sep; 27(3):228-233. PubMed ID: 27601177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and optimization of nanoemulsion using antifungal lipid and surfactant for accentuated topical delivery of Amphotericin B.
    Hussain A; Singh VK; Singh OP; Shafaat K; Kumar S; Ahmad FJ
    Drug Deliv; 2016 Oct; 23(8):3101-3110. PubMed ID: 27854145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention.
    Duret C; Merlos R; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Eur J Pharm Biopharm; 2014 Jan; 86(1):46-54. PubMed ID: 23523546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
    Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
    Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
    Jansook P; Fülöp Z; Ritthidej GC
    Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to enhance oral delivery of amphotericin B: a comparison of uncoated and enteric-coated nanostructured lipid carriers.
    Nimtrakul P; Sermsappasuk P; Tiyaboonchai W
    Drug Deliv; 2020 Dec; 27(1):1054-1062. PubMed ID: 32633144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
    Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
    J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM; Sivak O; Rosland M; Risovic V; Bartlett K
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocarrier-based topical drug delivery for an antifungal drug.
    Hussain A; Samad A; Nazish I; Ahmed FJ
    Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.